SCHEMBL6186896

SCHEMBL6186896

CC(=O)CC(SC(c1ccc(Cl)cc1)c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.47
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
CACNA2D1 P54289 4/20 0.41
CACNB1 Q02641 4/20 0.41
CACNA1A O00555 1/20 0.41
CNR1 P21554 1/20 0.40
POLB P06746 1/20 0.40
FFAR1 O14842 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
CACNA1B Q00975 3/20 0.39
CACNA1C Q13936 3/20 0.39
CACNA1G O43497 1/20 0.39
HSD17B10 Q99714 1/20 0.39
BRD4 O60885 1/20 0.39
GABBR2 O75899 2/20 0.39
GABBR1 Q9UBS5 2/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6188068 0.77 BRD4 (0.46) SLC6A4SLC6A3CACNA2D1CACNB1CACNA1A
SCHEMBL20544320 0.75 KDM4E (0.40) KDM4EALDH1A1MAPTHSD17B10LMNA
SCHEMBL23531383 0.73 PDPK1 (0.44) PDPK1SLC6A3POLBKDM4EALDH1A1
SCHEMBL11356933 0.72 KMT2A (0.48) PDPK1SLC6A4SLC6A3CNR1POLB
SCHEMBL8895206 0.71 PDPK1 (0.43) PDPK1SLC6A3POLBKDM4EALDH1A1
SCHEMBL6186361 0.71 PPARG (0.43) SLC6A4SLC6A3BRD4
SCHEMBL20544211 0.70 PDPK1 (0.60) PDPK1SLC6A3FFAR1KDM4EALDH1A1
Chlorobenzene SCHEMBL27979453 0.70 SCN4A (0.46) KDM4EALDH1A1MAPTGABBR2GABBR1
SCHEMBL10334603 0.70 PDPK1 (0.60) PDPK1SLC6A4SLC6A3POLB
SCHEMBL11733684 0.70 NTSR1 (0.56) PDPK1POLBKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539685-A1 MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF Warner-Lambert Company LLC (US) 2005-06-15 EP disclosed
WO-2004014847-A1 MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed